CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

114 hedge funds and large institutions have $209M invested in Cymabay Therapeutics in 2020 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+12
Holders Change %
+11.76%
% of All Funds
2.34%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.08%
New
36
Increased
31
Reduced
34
Closed
24
Calls
$2.07M
Puts
$1.69M
Net Calls
+$384K
Net Calls Change
-$571K
Name Holding Trade Value Shares
Change
Shares
Change %
Principal Financial Group
126
Principal Financial Group
Iowa
-$31K -20,686 Closed
DT
127
Diversified Trust
Tennessee
-$29K -19,381 Closed
DTL
128
Dynamic Technology Lab
Singapore
-$26K -17,580 Closed
ASRS
129
Arizona State Retirement System
Arizona
-$21K -14,516 Closed
AB
130
Amalgamated Bank
New York
-$18K -12,209 Closed
BRWA
131
B. Riley Wealth Advisors
Florida
-$16K -10,275 Closed
Zurich Cantonal Bank
132
Zurich Cantonal Bank
Switzerland
-$6K -4,015 Closed
MAM
133
Meeder Asset Management
Ohio
-$5K -3,519 Closed
Canada Life
134
Canada Life
Manitoba, Canada
-$5K -3,266 Closed
EW
135
Evoke Wealth
California
-$1.5K -1,015 Closed